Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Page 1
Sarcopenia index as a predictor of clinical outcomes in older patients undergoing transcatheter aortic valve replacement.
Romeo FJ, Chiabrando JG, Seropian IM, Raleigh JV, de Chazal HM, Garmendia CM, Smietniansky M, Cal M, Agatiello CR, Berrocal DH. Romeo FJ, et al. Among authors: berrocal dh. Catheter Cardiovasc Interv. 2021 Nov 15;98(6):E889-E896. doi: 10.1002/ccd.29799. Epub 2021 May 27. Catheter Cardiovasc Interv. 2021. PMID: 34043281
In multivariate Cox regression analysis, we identified low SI (cutoff 66) as an independent predictor of long-term adverse outcomes (HR = 4.01, 95% CI = 1.31-12.27, p = .015) at 1-year follow-up. ...
In multivariate Cox regression analysis, we identified low SI (cutoff 66) as an independent predictor of long-term adverse outcomes ( …
Long-term outcomes of percutaneous or surgical treatment in left main disease.
Chiabrando JG, Vescovo GM, Lombardi M, Del Buono MG, Romeo FJ, Berrocal DH, Guzman L, Biondi-Zoccai G, Abbate A. Chiabrando JG, et al. Among authors: berrocal dh. Minerva Cardiol Angiol. 2021 Jun;69(3):313-321. doi: 10.23736/S2724-5683.20.05370-0. Epub 2020 Nov 4. Minerva Cardiol Angiol. 2021. PMID: 33146478
INTRODUCTION: Long-term efficacy and safety of either surgical or percutaneous treatment left main coronary artery disease treatment is lacking. ...CONCLUSIONS: LMCA PCI has an overall same survival compared to CABG in the long term follow-up. Nevertheless, MACE and …
INTRODUCTION: Long-term efficacy and safety of either surgical or percutaneous treatment left main coronary artery disease treatment …
Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review.
Chiabrando JG, Bonaventura A, Vecchié A, Wohlford GF, Mauro AG, Jordan JH, Grizzard JD, Montecucco F, Berrocal DH, Brucato A, Imazio M, Abbate A. Chiabrando JG, et al. Among authors: berrocal dh. J Am Coll Cardiol. 2020 Jan 7;75(1):76-92. doi: 10.1016/j.jacc.2019.11.021. J Am Coll Cardiol. 2020. PMID: 31918837 Free article. Review.
Acute pericarditis is generally self-limited and not life-threatening; yet, it may cause significant short-term disability, be complicated by either a large pericardial effusion or tamponade, and carry a significant risk of recurrence. ...
Acute pericarditis is generally self-limited and not life-threatening; yet, it may cause significant short-term disability, be compli …
Balloon rupture during aortic valvuloplasty with compliant balloon: predictors and outcomes.
Seropian IM, Romeo FJ, Falconi M, Agatiello CR, Berrocal DH. Seropian IM, et al. Among authors: berrocal dh. Cardiovasc Interv Ther. 2020 Jul;35(3):291-299. doi: 10.1007/s12928-019-00623-8. Epub 2019 Sep 19. Cardiovasc Interv Ther. 2020. PMID: 31538307
Baseline echocardiography and computed tomography (CT) were analyzed. Best cutoff point for calcium score was assessed. Long-term mortality was analyzed with Kaplan-Maier. In vitro test was performed. ...No patient with rupture had any complication. One-month and long-t …
Baseline echocardiography and computed tomography (CT) were analyzed. Best cutoff point for calcium score was assessed. Long-term mor …
Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
Berrocal DH, Cohen MG, Spinetta AD, Ben MG, Rojas Matas CA, Gabay JM, Magni JM, Nogareda G, Oberti P, Von Schulz C, Doval H, Bazzino OO, Cagide A, Oliveri R, Grinfeld LR. Berrocal DH, et al. Am Heart J. 2003 Dec;146(6):E22. doi: 10.1016/S0002-8703(03)00424-1. Am Heart J. 2003. PMID: 14661011 Clinical Trial.
Secondary end points included infarct vessel patency rates before hospital discharge and short- and long-term outcomes. Patients with ischemic chest pain with duration < or =12 hours and no contraindication for thrombolytic therapy were included. ...
Secondary end points included infarct vessel patency rates before hospital discharge and short- and long-term outcomes. Patients with …